Maternal Use of SSRIs Associated with Fewer Depressive Symptoms, Delayed Fetal Head Growth
JAMA - Journal of the American Medical AssociationTreating pregnant women with selective serotonin reuptake inhibitors (SSRIs) appears to be associated with fewer depressive symptoms, reduced fetal head growth and a higher risk for preterm birth, but not with a delay in fetal body growth, according to a report published Online First by Archives of General Psychiatry, one of the JAMA/Archives journals.